Pill imprint 7.5 has been identified as Meloxicam 7.5 mg.
Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; tendonitis; fibromyalgia (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Meloxicam 7.5 mg is not subject to the Controlled Substances Act.
Please see the link: https://www.drugs.com/imprints/7-5-12757.html
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.